SCHEMBL10967799

SCHEMBL10967799

N#Cc1cccc(OCC([NH])=O)c1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ GAA P10253 1/20 0.49
▸ GPR34 Q9UPC5 1/20 0.48
▸ GSK3B P49841 1/20 0.44
▸ SMPD1 P17405 1/20 0.44
▸ TBXAS1 P24557 1/20 0.44
▸ FFAR1 O14842 1/20 0.44
▸ FFAR4 Q5NUL3 1/20 0.44
▸ PRMT5 O14744 1/20 0.43
▸ WDR77 Q9BQA1 1/20 0.43
▸ MGLL Q99685 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190220 0.85 ALOX15 (0.61) SMN1; SMN2GAAGPR34FFAR1FFAR4
SCHEMBL10967825 0.84 SMN1; SMN2 (0.54) SMN1; SMN2GAAGPR34GSK3BSMPD1
SCHEMBL16661979 0.84 SMN1; SMN2 (0.54) SMN1; SMN2GAAGPR34GSK3BSMPD1
SCHEMBL4394518 0.84 SMN1; SMN2 (0.54) SMN1; SMN2GAAGPR34GSK3BSMPD1
SCHEMBL4841249 0.81 SMN1; SMN2 (0.55) SMN1; SMN2GAAGPR34
SCHEMBL10971279 0.81 MAPT (0.53) GAA
SCHEMBL10289328 0.79 PPARA (0.55) SMN1; SMN2GAA
SCHEMBL16834804 0.77 MAPT (0.57) SMN1; SMN2MGLL
SCHEMBL16855859 0.77 ALDH1A1 (0.54) SMN1; SMN2GAA
SCHEMBL27248916 0.77 SMN1; SMN2 (0.57) SMN1; SMN2GAAGPR34PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0060119-B1 AZETIDINONE COMPOUNDS AND THEIR PREPARATION ELI LILLY AND COMPANY (US) 1985-04-10 — — EP disclosed
US-4500456-A AND AZETIDINONE-4-SULFINIC ACID, OR SALT THEREOF ELI LILLY AND COMPANY (US) 1985-02-19 — — US disclosed
EP-0060120-B1 PROCESS FOR PREPARING 4-HALOAZETIDIN-2-ONES ELI LILLY AND COMPANY (US) 1984-12-19 — — EP disclosed
EP-0019401-B1 PROCESS FOR PREPARING ENAMINE DERIVATIVES, COMPOUNDS SO PRODUCED AND PROCESS FOR PREPARING A 3-HYDROXY-CEPHALOSPORIN Lilly Industries Limited (GB) 1984-03-21 — — EP disclosed
US-4368156-A USING POSITIVE HALOGEN REAGENT ELI LILLY AND COMPANY (US) 1983-01-11 — — US disclosed
EP-0060120-A1 Process for preparing 4-haloazetidin-2-ones ELI LILLY AND COMPANY (US) 1982-09-15 — — EP disclosed
EP-0060119-A1 Azetidinone compounds and their preparation ELI LILLY AND COMPANY (US) 1982-09-15 — — EP disclosed
US-4301280-A Preparation of 3-substituted cephalosporins LILLY INDUSTRIES LIMITED (GB) 1981-11-17 — — US disclosed
EP-0019401-A1 Process for preparing enamine derivatives, compounds so produced and process for preparing a 3-hydroxy-cephalosporin Lilly Industries Limited (GB) 1980-11-26 — — EP disclosed
US-4176231-A Process for preparing 3-exomethylenecepham sulfoxides LILLY INDUSTRIES LIMITED (GB) 1979-11-27 — — US disclosed
US-4159266-A AZETIDINONE SULFINIC ACID DERIVATIVES ELI LILLY AND COMPANY (US) 1979-06-26 — — US disclosed
US-4052387-A METHOD OF PREPARATION OF 3-METHYLENECEPHAMS ELI LILLY AND COMPANY (US) 1977-10-04 — — US disclosed
US-4048160-A Process for preparation of 7-alkoxy-3-bromomethylcephems ELI LILLY AND COMPANY (US) 1977-09-13 — — US disclosed
US-4048163-A Process for preparation of 7-alkoxy-3-chloromethylcephems ELI LILLY AND COMPANY (US) 1977-09-13 — — US disclosed
US-4042585-A Process for preparation of 3-halomethylcephems ELI LILLY AND COMPANY (US) 1977-08-16 — — US disclosed
Send feedback